Anti-T Lymphocyte Immunoglobulin For Human Use, Rabbit

• Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients: a Spanish Multicenter, Randomized, Controlled Pa… Pending
  2024-519895-23-00 Phase II/III 1 country Fundacion Canaria Instituto De Investigacion Sanitaria De Canarias
• Prospective Phase II study on Safety and Efficacy of Fludarabine plus Treosulfan (14g) (FT14) conditioning regimen for allogeneic Stem Cell … Pending
  2024-520326-11-00 Phase II 1 country Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia
• Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL. Recruiting
  2025-522052-13-00 Phase II/III 9 countries Ospedale Pediatrico Bambino Gesu
• Stem cell transplantation in diffuse cutaneous systemic sclerosis: upfront therapy or rescue therapy after failure of immunosuppressants Recruiting
  2023-505877-34-00 Phase IV 3 countries University Medical Center Utrecht
• Cumulative exposure to Fludarabine in patients undergoing reduced intensity allogeneic stem cell transplantation in Belgium Recruiting
  2023-503723-26-00 Phase IV 1 country Universitair Ziekenhuis Gent
• A clinical trial applying Regulatory T cells in kidney transplant recipients to investigate the safety and tolerability as an adjunctive the… Recruiting
  2024-514398-23-00 Phase I/II 1 country Charite Universitaetsmedizin Berlin KöR
• Grafalon®therapy within 12 weeks of Type 1 diabetes (T1D) diagnosis in children and young adults to prevent the loss of residual beta cell f… Recruiting
  2023-508514-42-00 Phase II 1 country Institute For Clinical And Experimental Medicine; University Hospital Kralovske …
• Study comparing thymoglobulin to grafalon, two treatments used to prevent graft versus host disease in elderly patients with acute myeloid l… Recruiting
  2023-504555-27-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• FLUCLORIC - Randomized multicentric Phase III study comparing the efficacy of two reduced intensity conditioning regimens (clofarabine/busul… Recruiting
  2022-502019-12-00 Phase III 1 country Centre Hospitalier Universitaire De Nantes
• TCRaß+CD19+ depleted haploidentical stem cell transplantation followed by immunotherapy in patients with relapsed/resistant high-risk neurob… Recruiting
  2024-519089-32-02 Phase II 1 country IRCCS Istituto Giannina Gaslini
• Studying Conditioning Regimen In Pediatric Transplantation -AML Recruiting
  2023-505512-37-00 Phase III 6 countries Vaestra Goetalandsregionen
• Trial of efficacy and safety of MC0518 versus best available therapy in patients with steroid-refractory acute graft versus host disease Ended
  2023-503952-28-00 Phase II 5 countries Medac Gesellschaft fuer klinische Spezialprapaerate mbH
• GRAPPA Ended
  2023-510441-24-00 Phase III 1 country DKMS Group gGmbH
• A 12-Month Clinical Research Study to evaluate a new investigational medication (siplizumab) compared to another medication (anti thymocyte … Ended
  2023-507895-36-00 Phase II 3 countries Itb-Med AB

Showing 1–14 of 14 trials